Literature DB >> 22937717

[Unusual forms of persistence of Mycoplasma hominis in organism of infected humans].

G A Levina, O I Barkhatova, L G Gorina, N A Gamova, S A Goncharova, T M Raskova, I N Rastegaeva, N A Seliverstova, I V Rakovskaia.   

Abstract

AIM: Study previously unknown forms of persistence of Mycoplasma hominis in host organism.
MATERIALS AND METHODS: Culture method was used for detection of mycoplasmas. Identification was carried out by serological, electron microscopy methods, classic PCR and real time PCR; circulating immune complexes (CIC) were isolated by PEG precipitation.
RESULTS: Classic micoplasma cultures could not be isolated from blood even once. At the same time "mini-colony" cultures composed of mini-cells that were hardly passaged but sometimes formed continuous layer of the same colonies were isolated from blood serum samples with high frequency. During reseeding for more than 1 year they never acquired classic form. Not only antigens of M. hominis but its DNA were shown to be present in CIC. Viable cells forming "mini-colonies" identical to those isolated from blood sera were isolated from circulating immune complexes. A system of evidence on identity of isolated M. hominis cultures is presented. Cultures had infectivity and an ability to persist in organs of experimentally infected mice.
CONCLUSION: The isolated forms are apparently the result of adaptation of mycoplasmas to humoral immunity factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22937717

Source DB:  PubMed          Journal:  Zh Mikrobiol Epidemiol Immunobiol        ISSN: 0372-9311


  1 in total

1.  Thymidine utilisation pathway is a novel phenotypic switch of Mycoplasma hominis.

Authors:  Gleb Yu Fisunov; Olga V Pobeguts; Valentina G Ladygina; Alexandr I Zubov; Mariya A Galyamina; Sergey I Kovalchuk; Rustam K Ziganshin; Daria V Evsyutina; Daria S Matyushkina; Ivan O Butenko; Olga N Bukato; Vladimir A Veselovsky; Tatiana A Semashko; Ksenia M Klimina; Galina A Levina; Olga I Barhatova; Irina V Rakovskaya
Journal:  J Med Microbiol       Date:  2022-01       Impact factor: 2.472

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.